International interlaboratory digital PCR study demonstrating high reproducibility for the measurement of a rare sequence variant

…, F Fina, T Forshew, R Fredslund Andersen… - Analytical …, 2017 - ACS Publications
This study tested the claim that digital PCR (dPCR) can offer highly reproducible quantitative
measurements in disparate laboratories. Twenty-one laboratories measured four blinded …

Protein levels and gene expressions of the epidermal growth factor receptors, HER1, HER2, HER3 and HER4 in benign and malignant ovarian tumors

…, R Fredslund Andersen… - International …, 2008 - spandidos-publications.com
… Baekelandt M, Kristensen GB, Trope CG, Nesland JM and Holm R: Epidermal growth factor
receptor expression has no independent prognostic significance in advanced ovarian cancer…

Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility

…, M Støchkel Frank, R Fredslund Andersen… - Cancer, 2022 - Wiley Online Library
This commentary attempts to discuss the required standardization of circulating tumor DNA
(ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the …

[HTML][HTML] Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer

KLG Spindler, N Pallisgaard, RF Andersen… - PloS one, 2015 - journals.plos.org
Background Circulating cell-free DNA (cfDNA) in plasma has shown potential as biomarker
in various cancers and could become an importance source for tumour mutation detection. …

The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer

…, KLG Spindler, N Pallisgaard, RF Andersen… - Lung cancer, 2013 - Elsevier
BACKGROUND: Lung cancer is one of the most common malignant diseases worldwide and
associated with considerable morbidity and mortality. New agents targeting the epidermal …

Changes in mutational status during third‐line treatment for metastatic colorectal cancer—Results of consecutive measurement of cell free DNA, KRAS and BRAF in …

…, N Pallisgaard, RF Andersen… - … journal of cancer, 2014 - Wiley Online Library
KRAS and BRAF mutations are responsible for primary resistance to epidermal growth factor
receptor (EGFR) MoAbs in metastatic colorectal cancer (mCRC), but it is unknown what …

[HTML][HTML] Quantification of microRNA levels in plasma–impact of preanalytical and analytical conditions

…, JS Madsen, NHH Heegaard, K Houlind, RF Andersen… - PloS one, 2018 - journals.plos.org
Numerous studies have reported a potential role for circulating microRNAs as biomarkers in
a wide variety of diseases. However, there is a critical reproducibility challenge some of …

Controls to validate plasma samples for cell free DNA quantification

N Pallisgaard, KLG Spindler, RF Andersen… - Clinica Chimica …, 2015 - Elsevier
Recent research has focused on the utility of cell free DNA (cfDNA) in serum and plasma for
clinical application, especially in oncology. The literature holds promise of cfDNA as a …

[HTML][HTML] Delta tocotrienol in recurrent ovarian cancer. A phase II trial

CB Thomsen, RF Andersen, KD Steffensen… - Pharmacological …, 2019 - Elsevier
Delta tocotrienol has anti-neoplastic activity as demonstrated in several in-vitro and in-vivo
investigations. The effect relies on inhibition of different pathways. It also has antiangiogenic …

[HTML][HTML] Clinical utility of KRAS status in circulating plasma DNA compared to archival tumour tissue from patients with metastatic colorectal cancer treated with anti …

…, N Pallisgaard, AL Appelt, RF Andersen… - European journal of …, 2015 - Elsevier
… Author links open overlay panel Karen-Lise Garm Spindler a c , Niels Pallisgaard b , Ane
Lindegaard Appelt c , Rikke Fredslund Andersen b , Jakob V. Schou d , Dorte Nielsen d g , Per …